Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome (2024)

Related Papers

Journal of Neurology, Neurosurgery & Psychiatry

Long-term outcome of thalamic deep brain stimulation in two patients with Tourette syndrome

2010 •

Annelien Duits

View PDF

Open Access Macedonian Journal of Medical Sciences

Long-term Outcome of Deep Brain Stimulation in Intralaminar Thalamus for Refractory Tourette Syndrome: A Case Report

ina dianata, Agus Mahendra, rocksy situmeang

BACKGROUND: Tourette syndrome (TS) is a neurobehavioral disease that has onset at an early age around 5–7 years old. This disease affects 0.3–0.8% of young age population. With criteria diagnosis at least one vocal and two motor tics beginning before 18 years old. The symptoms of tics remain unusual from a social point of view, thus making it difficult for patients to evolve their professional life and education level. We present a case report of a young male patient with refractory TS with a Yale Global Tic Severity Scale (YGTSS) score of 88 out of 100; he has experienced remarkable improvement after undergoing a deep brain stimulation (DBS) procedure. CASE REPORT: A 23-year-old male came to our neurosurgery outpatient clinic who had had a history of TS since 8 years ago. He had facial and jumping-type tics. Lately, his jumping movements cannot be controlled, with increasing frequency and intensity. The maximum tic-free interval is only 30 min. On 1st-time evaluation in the neurosu...

View PDF

Journal of Neurosurgery

Neuroanatomical considerations for optimizing thalamic deep brain stimulation in Tourette syndrome

2021 •

Yuki Sakai, Takashi Morish*ta

OBJECTIVE Deep brain stimulation (DBS) of the centromedian thalamic nucleus has been reportedly used to treat severe Tourette syndrome, yielding promising outcomes. However, it remains unclear how DBS electrode position and stimulation parameters modulate the specific area and related networks. The authors aimed to evaluate the relationships between the anatomical location of stimulation fields and clinical responses, including therapeutic and side effects. METHODS The authors collected data from 8 patients with Tourette syndrome who were treated with DBS. The authors selected the active contact following threshold tests of acute side effects and gradually increased the stimulation intensity within the therapeutic window such that acute and chronic side effects could be avoided at each programming session. The patients were carefully interviewed, and stimulation-induced side effects were recorded. Clinical outcomes were evaluated using the Yale Global Tic Severity Scale, the Yale-Brown Obsessive-Compulsive Scale, and the Hamilton Depression Rating Scale. The DBS lead location was evaluated in the normalized brain space by using a 3D atlas. The volume of tissue activated was determined, and the associated normative connective analyses were performed to link the stimulation field with the therapeutic and side effects. RESULTS The mean follow-up period was 10.9 ± 3.9 months. All clinical scales showed significant improvement. Whereas the volume of tissue activated associated with therapeutic effects covers the centromedian and ventrolateral nuclei and showed an association with motor networks, those associated with paresthesia and dizziness were associated with stimulation of the ventralis caudalis and red nucleus, respectively. Depressed mood was associated with the spread of stimulation current to the mediodorsal nucleus and showed an association with limbic networks. CONCLUSIONS This study addresses the importance of accurate implantation of DBS electrodes for obtaining standardized clinical outcomes and suggests that meticulous programming with careful monitoring of clinical symptoms may improve outcomes.

View PDF

Journal of Neurosurgery

Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome

2003 •

Henry Colle

✓✓ Based on the results of thalamotomies described by Hassler in 1970, the authors performed bilateral thalamic highfrequency stimulation (HFS) in three patients with intractable Tourette syndrome (TS). In this report they describe the long-term effects. Three male patients (42, 28, and 45 years of age) had manifested motor and vocal tics since early childhood. The diagnosis of TS was made according to the criteria of the Tourette Syndrome Classification Study Group. Any drug or alternative treatment had been either ineffective or only temporarily effective in all three patients. There was no serious comorbidity. The target for stimulation was chosen at the level of the centromedian nucleus, substantia periventricularis, and nucleus ventrooralis internus. After 2 weeks of test stimulation, the pulse generators were implanted. After a follow-up period of 5 years in the patient in Case 1, 1 year in the patient in Case 2, and 8 months in the patient in Case 3, all major motor and vocal...

View PDF

Parkinsonism & Related Disorders

Scheduled, intermittent stimulation of the thalamus reduces tics in Tourette syndrome

2016 •

Kelly Foote

View PDF

Translational Psychiatry

Clinical effectiveness of unilateral deep brain stimulation in Tourette syndrome

2011 •

Joachim Klosterkötter, Joerg Daumann, Christiane Woopen

View PDF

Journal of Neurology Neurosurgery and Psychiatry

Tourette’s syndrome and deep brain stimulation

2005 •

Soledad Navarro

View PDF

Archives of Neurology

Internal Pallidal and Thalamic Stimulation in Patients With Tourette Syndrome

2008 •

Didier Dormont

View PDF

PLoS ONE

Increased Thalamic Gamma Band Activity Correlates with Symptom Relief following Deep Brain Stimulation in Humans with Tourette’s Syndrome

2012 •

Kelly Foote

View PDF

Movement Disorders

Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome

2006 •

Danielle Cath

View PDF
Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome (2024)

FAQs

What is the new treatment for Tourette's? ›

Deep brain stimulation works like a pacemaker, but it's used in the brain instead of in the heart. This technique requires the surgical placement of a small conductor called an electrode in the brain. This conductor delivers electrical stimulation that blocks the nerve signals that cause tics.

How much does deep brain stimulation surgery cost? ›

What Does Deep Brain Stimulation Cost? The cost of deep brain stimulation varies depending on where you live. In the United States, the cost of surgery (including the implanted device, hospital fees and anesthesia) can range from $35,000 to $100,000.

What is the target of DBS for Tourette's? ›

The four most commonly used DBS targets for TS include the centromedian nucleus–nucleus ventrooralis internus (CM-Voi) and the centromedian nucleus–parafascicular (CM-Pf) complexes of the thalamus, and the posteroventrolateral (pvIGPi) and the anteromedial portion of the globus pallidus internus (amGPi).

What is the experimental treatment for Tourette's? ›

The prototype wrist device, which was recently tried out by Lewis Capaldi, delivers electrical pulses to reduce the amount and severity of tics experienced by individuals with Tourette's and was trialed by 121 people across the UK. The results have been announced in MedRxive.

Has anyone ever been cured of Tourette's? ›

There's no cure for Tourette's syndrome and most children with tics do not need treatment for them. Treatment may sometimes be recommended to help you control your tics. Treatment is usually available on the NHS and can involve: behavioural therapy.

What helps calm down Tourette's? ›

Medication
  • Medications that block or lessen dopamine. Fluphenazine, haloperidol (Haldol), risperidone (Risperdal) and pimozide (Orap) can help control tics. ...
  • Botulinum (Botox) injections. ...
  • ADHD medications. ...
  • Central adrenergic inhibitors. ...
  • Antidepressants. ...
  • Antiseizure medications.
Aug 8, 2018

What is the downside to DBS? ›

Side effects associated with deep brain stimulation may include: Seizure. Infection. Headache.

What is the survival rate for deep brain stimulation surgery? ›

Survival rates dropped over time, from 96.9% at one year after DBS to 52.5% at 12 years after the surgery. The most common cause of death was Parkinson's disease (47.1%) followed by injury, poisoning, and consequences of other external causes (15.9%); circulatory system diseases (12.8%); and tumors (5.2%).

What is life like after deep brain stimulation surgery? ›

Life after DBS surgery

Slowly return to regular activities. Falls: You have an especially high risk of falling in the weeks after DBS. Patients often feel overconfident after surgery. If you used a walker or cane before surgery, keep using it until you are stronger and steadier.

What is the gold standard for Tourette's? ›

The Yale Global Tic Severity Scale (YGTSS) is a clinician-rated instrument considered as the gold standard for assessing tics in patients with Tourette's Syndrome and other tic disorders.

What part of the brain controls Tourette's? ›

Most cases of TS involve the interaction of multiple gene variations and environmental factors. Although the cause of TS is unknown, current research points to abnormalities in: Certain brain regions, including the basal ganglia, frontal lobes, and cortex.

Is Tourette's considered special needs? ›

According to the Federal Department of Justice, Tourette Syndrome is a disability covered by the ADA.

What is the new drug for Tourette's? ›

Ecopipam is a first-in-class D1 receptor blocker in development for Tourette syndrome. What This Study Adds: In this randomized clinical trial, ecopipam, a D1 receptor blocker, was more effective than a placebo in reducing tic severity in children and adolescents with Tourette syndrome.

What therapy is best for Tourette's? ›

Behavioral therapy is a treatment that teaches people with TS ways to manage their tics. Behavioral therapy is not a cure for tics. However, it can help reduce the number of tics, the severity of tics, the impact of tics, or a combination of all of these.

What is the drug of choice for Tourette's syndrome? ›

The most frequently used drugs for tics are antipsychotics (mainly pimozide and haloperidol) and clonidine.

Do Tourette's tics get worse with age? ›

Most people with TS experience their worst tic symptoms in their early teens, but tics typically lessen and become controlled by the late teens to early 20s. For some people, TS can be a chronic condition with symptoms that last into adulthood. In some cases, tics may worsen in adulthood.

What makes Tourette's syndrome worse? ›

Tourette syndrome can be mild, moderate or severe. The intensity of symptoms can change within the person, sometimes on a daily basis. Stress or tension tends to make the condition worse, while relaxation or concentration eases the symptoms. Sometimes, the symptoms come and go over a period of months.

References

Top Articles
Latest Posts
Article information

Author: Greg O'Connell

Last Updated:

Views: 6673

Rating: 4.1 / 5 (42 voted)

Reviews: 81% of readers found this page helpful

Author information

Name: Greg O'Connell

Birthday: 1992-01-10

Address: Suite 517 2436 Jefferey Pass, Shanitaside, UT 27519

Phone: +2614651609714

Job: Education Developer

Hobby: Cooking, Gambling, Pottery, Shooting, Baseball, Singing, Snowboarding

Introduction: My name is Greg O'Connell, I am a delightful, colorful, talented, kind, lively, modern, tender person who loves writing and wants to share my knowledge and understanding with you.